Stepan Company (SCL)

NYSE Materials Specialty Chemicals S&P SmallCap 600
$66.94
-0.91 (-1.34%)
Close of Nov 06, 2026 · end-of-day data

SCL 8-K filings in 2026

Every material Form 8-K Stepan filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.

Briefs in 2026616 on record in all
Latest filing in 2026Oct 28, 2026earnings
High impact (4-5)3of 6 briefs
ToneMixed5Neutral1
earnings 4financing 1restructuring 1
Oct 28, 7:00 AM ET

Stepan Q3 Net Income Rises 64% to $17.8 Million; Quarterly Dividend Raised to $0.405

Mixed earnings 2.028.01

Stepan reported third quarter 2026 net sales of $692.2 million, up 17%, and net income of $17.8 million, up 64%, with diluted EPS of $0.78 versus $0.47. Nine-month results were a net loss of $0.7 million because of a $76.1 million pre-tax restructuring charge tied to Project Catalyst, and the company said it expects full-year Adjusted EBITDA growth and positive free cash flow in 2026. The board also declared a $0.405 quarterly dividend, a $0.010 increase.

  • Q3 2026 net sales $692.2 million, up 17% year-over-year; Q3 Adjusted EBITDA $66.3 million, up 18%
  • Nine months 2026 net loss of $0.7 million versus $41.9 million of income in 2025, driven by a $76.1 million pre-tax restructuring charge
  • Quarterly dividend of $0.405 per share, payable December 15, 2026, to holders of record on December 1, 2026; 59th consecutive annual increase
  • Company expects full-year 2026 Adjusted EBITDA growth, positive free cash flow and continued balance sheet de-leveraging
Read the filing on SEC.gov ↗
Sep 25, 9:47 PM ET

Stepan Co. signs $500 million credit agreement maturing in 2031, replacing older facilities

Neutral financing Written later 1.012.03

Stepan entered into a new Credit Agreement on September 25, 2026, providing $500.0 million in initial committed facilities: a $350.0 million multicurrency revolver and a $150.0 million delayed draw term loan, both maturing September 25, 2031. The new facilities replace its $350.0 million revolver and $100.0 million delayed draw term loan under a June 24, 2022 agreement, and include an option for up to an additional $250.0 million, giving the company expanded, longer-dated borrowing capacity.

  • Initial facilities total $500.0 million: $350.0 million revolver and $150.0 million delayed draw term loan, both maturing September 25, 2031
  • Replaces the $350.0 million revolver and $100.0 million delayed draw term loan from a June 24, 2022 credit agreement
  • Expansion option allows up to an additional $250.0 million, subject to certain requirements
  • Loans priced at spreads of 1.125% to 1.625% over term benchmark rates, depending on net leverage ratio; covenants include interest coverage and net leverage ratios
Read the filing on SEC.gov ↗
Jul 29, 7:00 AM ET

Stepan Q2 net income up 102% to $22.9 million; first-half loss on $70.5 million charge

Mixed earnings Written later 2.022.055.028.01

Stepan reported second-quarter 2026 net income of $22.9 million, up 102% from a year earlier, on net sales of $684.1 million, up 15%. The first half was a net loss of $18.5 million, driven by a $70.5 million pre-tax restructuring charge tied to Project Catalyst, and the company also announced a plan to cut about 100 salaried roles, declared a $0.395 quarterly dividend, and reported a board resignation and a new principal accounting officer.

  • Q2 2026 diluted EPS was $1.00 versus $0.50; adjusted EPS was $1.18 versus $0.52.
  • Q2 adjusted EBITDA was $74.4 million, up 45%, and management said it expects full-year 2026 adjusted EBITDA growth.
  • Full-year Project Catalyst restructuring charges are expected to be $75.0 million to $80.0 million, with about $4 million to $6 million tied to the workforce reduction.
  • Jan Stern Reed resigned from the board on July 27, 2026; Matthew J. Eaken was named principal accounting officer effective July 28, 2026.
Read the filing on SEC.gov ↗
Apr 28, 7:00 AM ET

Stepan posts $41.4 million Q1 loss on $65.4 million restructuring charge

Mixed earnings Written later 2.028.01

Stepan Company reported a first-quarter 2026 net loss of $41.4 million, or $1.81 per diluted share, compared with net income of $19.7 million a year earlier, after a $65.4 million pre-tax restructuring charge tied to previously announced plant closures. Net sales rose 2% to $604.5 million, but adjusted net income fell 47% to $10.3 million, and the company also declared a quarterly dividend of $0.395 per share.

  • Net loss of $41.4 million ($1.81 per diluted share) versus net income of $19.7 million ($0.86 per share) in Q1 2025; the loss includes a $65.4 million pre-tax restructuring charge
  • Adjusted net income of $10.3 million ($0.45 per diluted share), down 47% from $19.3 million; adjusted EBITDA of $49.6 million, down 14%
  • Net sales rose 2% to $604.5 million, driven by higher selling prices and currency translation; organic sales volume was flat
  • Board declared a quarterly dividend of $0.395 per share, payable June 15, 2026, to holders of record on June 1, 2026
Read the filing on SEC.gov ↗
Feb 23, 7:05 AM ET

Stepan to close Fieldsboro plant, take $70-80 million in 2026 restructuring charges

Mixed restructuring Written later 2.057.01

Stepan Company approved Project Catalyst, a plan targeting about $100 million in pre-tax savings over two years. The plan closes its Fieldsboro, New Jersey site and decommissions select assets at Elwood, Illinois and Stalybridge, United Kingdom, with completion expected by mid-2026. The company expects $70 to $80 million in restructuring charges in 2026, which will weigh on near-term results against the projected savings.

  • Target of approximately $100 million in pre-tax savings over the next two years
  • Restructuring charges of $70 to $80 million expected in 2026, with about $52 to $62 million in the three months ending March 31, 2026
  • Projected cash impacts of $29 to $44 million and non-cash impacts of $58 to $62 million over the project
  • Fieldsboro site closure and asset decommissioning expected to be completed by mid-2026
Read the filing on SEC.gov ↗
Feb 23, 7:00 AM ET

Stepan Q4 adjusted net loss of $0.5 million; full-year net income down 7%

Mixed earnings Written later 2.028.01

Stepan reported fourth-quarter and full-year 2025 results and announced Project Catalyst, a plan it says is expected to deliver about $100 million in pre-tax savings over two years, including closing its Fieldsboro, NJ site. Full-year 2025 net income fell 7% to $46.9 million and adjusted earnings per diluted share fell 17% to $1.82, while net sales rose 7% to $2.33 billion. The company also declared a $0.395 quarterly dividend payable March 13, 2026.

  • Q4 2025 net income was $5.0 million, up 49%; adjusted net income was a $0.5 million loss versus $2.8 million of income a year earlier
  • Full-year 2025 adjusted EBITDA was $198.9 million, up 6%; net sales were $2.33 billion, up 7%
  • Project Catalyst is expected to deliver about $100 million in pre-tax savings over two years and includes closing the Fieldsboro, NJ site
  • Quarterly dividend of $0.395 per share is payable March 13, 2026, to holders of record on March 2, 2026
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Stepan filing is on SEC EDGAR ↗. 8-K briefs of other companies →